Product approvals

In this April 23, 2018, photo, Meagan Patrick kisses her daughter, Addelyn Patrick, 5, in the playroom at Realm of Caring in Colorado Springs, Colo. Addelyn was born with a brain malformation and suffers from multiple forms of seizures. The U.S. Food and Drug Administration is expected to decide soon whether to give its first approval to a prescription drug made from the marijuana plant. But parents, including Meagan, who have used other products containing chemicals from the plant to treat their children’s severe forms of epilepsy are feeling more cautious than celebratory. (AP Photo/Thomas Peipert)
June 19, 2018 - 2:11 am
COLORADO SPRINGS, Colorado (AP) — The U.S. Food and Drug Administration is expected to decide soon whether to give its first approval to a prescription drug made from the marijuana plant. But parents who have used other products containing chemicals from the plant to treat their children's severe...
Read More
June 04, 2018 - 3:00 am
BERLIN (AP) — German pharmaceutical company Bayer AG said Monday that it plans to complete its purchase of U.S. seed and weed-killer maker Monsanto Co. this week after receiving all the required approvals from regulators. Bayer said in a statement that it plans to complete the acquisition on...
Read More
President Donald Trump hugs Duchenne Muscular Dystrophy patient Jordan McLinn after signing the "Right to Try" act in the South Court Auditorium on the White House campus, Wednesday, May 30, 2018, in Washington. (AP Photo/Evan Vucci)
May 30, 2018 - 2:03 pm
WASHINGTON (AP) — President Donald Trump signed legislation Wednesday aimed at helping people with deadly diseases try experimental treatments, calling it a "fundamental freedom" that will offer hope and save lives. Joined by families dealing with amyotrophic lateral sclerosis, also called Lou...
Read More
This May 10, 2018, image provided by Amgen Inc. shows an artist's rendering of the packaging for the drug Aimovig, the first in a new class of long-acting drugs designed to prevent chronic migraines. On Thursday, May 17, 2018, the Food and Drug Administration approved the medication, clearing the monthly shot for sale. (Amgen Inc. via AP)
May 17, 2018 - 7:24 pm
TRENTON, N.J. (AP) — U.S. regulators Thursday approved the first drug designed to prevent chronic migraines. The Food and Drug Administration's action clears the monthly shot Aimovig (AIM'-oh-vig) for sale. It's the first in a new class of long-acting drugs for preventing migraines. Three other...
Read More
May 17, 2018 - 8:38 am
TOKYO (AP) — Japanese electronics company Toshiba Corp. says the sale of its computer memory chip business to a consortium led by Bain Capital Private Equity has cleared all anti-trust regulatory approval, including a final one it was awaiting from China. Toshiba said Thursday that means the deal,...
Read More
FILE - In this Friday, July 8, 2016 file photo, a prescription is filled at a pharmacy in Sacramento, Calif. On Friday, May 11 2018, Trump is scheduled to give his first speech on how his administration will seek to lower drug prices. (AP Photo/Rich Pedroncelli, File)
May 10, 2018 - 8:07 pm
WASHINGTON (AP) — Before taking office, President Donald Trump railed against the pharmaceutical industry and accused it of "getting away with murder." The populist rhetoric appears to be giving way to a more nuanced strategy focused on making the pharmaceutical market more open and competitive,...
Read More
FILE - This May 23, 2017 file photo shows GW Pharmaceuticals’ Epidiolex, a medicine made from the marijuana plant but without THC. On Thursday, April 19, 2018, a panel of Food and Drug Administration health advisers recommended approval of the drug, moving the closely watched medication closer to the U.S. market. (AP Photo/Kathy Young, File)
April 19, 2018 - 1:05 pm
WASHINGTON (AP) — A medicine made from the marijuana plant moved one step closer to U.S. approval Thursday after federal health advisers endorsed it for the treatment of severe seizures in children with epilepsy. If the Food and Drug Administration follows the group's recommendation, GW...
Read More
April 17, 2018 - 11:46 am
WASHINGTON (AP) — U.S. health officials on Tuesday proposed steps to improve the government's system for overseeing medical devices, which has been criticized for years for failing to catch problems with risky implants and medical instruments. The plan from the Food and Drug Administration includes...
Read More
FILE - In this Monday, Nov. 6, 2017 file photo, Brian Madeux sits with his girlfriend Marcie Humphrey while waiting to receive the first human gene editing therapy at the UCSF Benioff Children's Hospital in Oakland, Calif. Madeux, who has Hunter syndrome, received the treatment on Monday, Nov. 13. Gene therapy aims to treat the root cause of a problem by deleting, adding or altering DNA, rather than just treating symptoms that result from the genetic flaw. (AP Photo/Eric Risberg)
December 28, 2017 - 10:23 am
After decades of hope and high promise, this was the year scientists really showed they could doctor DNA to successfully treat diseases. Gene therapies to treat cancer and even pull off the biblical-sounding feat of helping the blind to see were approved by U.S. regulators, establishing gene...
Read More
November 30, 2017 - 9:25 pm
WASHINGTON (AP) — U.S. health officials on Thursday approved the first injectable form of the leading medication to treat patients recovering from addiction to heroin, prescription painkillers and other opioids. The Food and Drug Administration approved once-a-month Sublocade for adults with opioid...
Read More

Pages